Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease
Conditions: Rheumatoid Arthritis; Systemic Lupus; Sjögren Syndrome; Systemic Vasculitis; Spondyloarthritis Interventions: Biological: 13-valent pneumococcal conjugate vaccine; Biological: 23-valent pneumococcal polysaccharide vaccine Sponsor: Region Skane Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arthritis | Lupus | Meningitis Vaccine | Pneomococcal Vaccine | Rheumatology | Vaccines | Vasculitis